Showing results (261-270 of 291) with videos related to

Sort By:
Pageof 30
Cancers|July 20, 2021
Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular CarcinomaAnnabelle Vogt, Farsaneh Sadeghlar, Tiyasha H Ayub, et al.
The New England Journal of Medicine|June 1, 2007
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinomaGary Hudes, Michael Carducci, Piotr Tomczak, et al.
Journal of Neuropathology and Experimental Neurology|March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expressionCornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2003
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapyHendrik Pels, Ingo G H Schmidt-Wolf, Axel Glasmacher, et al.
Annals of Neurology|March 13, 2010
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphomaAnnika Juergens, Hendrik Pels, Sabine Rogowski, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Immunological Investigations|October 17, 2023
Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular CarcinomaFarsaneh Sadeghlar, Julia Seelemann, Annabelle Vogt, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2026
AI-Guided Additive Scoring Model for Differential Diagnosis of Primary Liver CancerRebekka J S Salzmann, Tudor Mocan, Arnulf G Willms, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study groupVerena I Gaidzik, Lars Bullinger, Richard F Schlenk, et al.
Pageof 30